Recettore del glucagone
I recettori del glucagone sono GPCR che mediano gli effetti del glucagone, un ormone coinvolto nella regolazione dell'omeostasi del glucosio promuovendo la degradazione del glicogeno e il rilascio di glucosio dal fegato. Questi recettori sono fondamentali nella gestione dei livelli di zucchero nel sangue e sono di particolare interesse nello studio del diabete e dei disturbi metabolici. Gli antagonisti dei recettori del glucagone sono studiati come potenziali trattamenti per l'iperglicemia nel diabete di tipo 2. Presso CymitQuimica, offriamo una varietà di modulatori dei recettori del glucagone di alta qualità per supportare la tua ricerca in endocrinologia, diabete e regolazione metabolica.
Trovati 209 prodotti per "Recettore del glucagone".
Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
DA-302168S
CAS:DA-302168S is an orally active, selective GLP-1R agonist with an EC50 value of 1.32 nM. It promotes insulin secretion and has a hypoglycemic effect. Additionally, DA-302168S reduces food intake. It primarily activates GLP-1R in humans and monkeys, with minimal effect on GLP-1R in rats, mice, and dogs. DA-302168S can be used for research in type 2 diabetes and obesity.Formula:C33H24ClF2N3O5Colore e forma:SolidPeso molecolare:616.011GLP-1R agonist 8
CAS:GLP-1R agonist 8 is a potent agonist of GLP-1R (EC50 < 2 nM).Formula:C33H32N4O5Colore e forma:SolidPeso molecolare:564.63Naperiglipron
CAS:Naperiglipron (LY3549492) (Example 2) is a glucagon-like peptide-1 receptor (GLP-1R) agonist with an EC50 of 1.14 nM for hGLP-1R. It markedly reduces blood glucose levels in GLP-1R gene knock-in mouse models. Additionally, Naperiglipron inhibits PDE10A1 enzyme activity (IC50: 7.43 μM) and exhibits weak hERG inhibitory activity. This compound is applicable in research on Type II diabetes mellitus (T2DM) and obesity.Formula:C33H26F2N4O4Peso molecolare:580.59DS79932728
CAS:DS79932728 is an orally active inhibitor of G9a and GLP, with IC50 values of 12.6 nM and 75.7 nM, respectively. It induces the production of γ-globin, thereby increasing fetal hemoglobin (HbF) levels. In cynomolgus monkey models, DS79932728 enhances the proportion of F-reticulocytes (F-rets) and shows good oral absorption characteristics.Formula:C19H25N3OColore e forma:SolidPeso molecolare:311.421GIPR antagonist 1
CAS:GIPR antagonist 1 is a GIPR inhibitor with an IC50 of 4.8 nM. It effectively suppresses the glucose-dependent insulinotropic polypeptide receptor signaling pathway. GIPR antagonist 1 is applicable in research related to type 2 diabetes and obesity.Formula:C28H29FN4O4Peso molecolare:504.55GLP-1R agonist 33
CAS:GLP-1R agonist 33 (Compound 224) is a GLP-1 receptor agonist with potential applications in research related to diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD).Formula:C30H27FN6O4Colore e forma:SolidPeso molecolare:554.57LSN3318839
CAS:LSN3318839 is a potent and orally available glucagon-like peptide-1 receptor (GLP-1R) modulator.LSN3318839 enhances GLP-1R G-protein-coupled signaling and canFormula:C26H23Cl2N3O2Purezza:99.70%Colore e forma:SolidPeso molecolare:480.39Retatrutide sodium salt
Retatrutide sodium salt is a glucagon receptor and glucagon-like peptide-1 receptor agonist for the study of type 2 diabetes mellitus.Purezza:99.86% - 99.97%Colore e forma:White SolidOrforglipron hemicalcium hydrate
CAS:Orforglipron hemicalcium hydrate (LY3502970 hemicalcium hydrate; GLP-1 receptor agonist 1 hemicalcium hydrate) represents the hemicalcium hydrate form of the calcium salt of Orforglipron, an orally active agonist targeting the Glucagon-like peptide-1 receptor (GLP-1R). This compound has demonstrated efficacy in mitigating type 2 diabetes [1].Formula:C48H48F2N10O5Ca·H2OColore e forma:SolidPeso molecolare:921.02Ref: TM-T87071
Prodotto fuori produzione
